Literature DB >> 7214789

Theophylline metabolism in premature infants.

K Y Tserng, K C King, F N Takieddine.   

Abstract

The theophylline metabolite pattern in premature infants was studied with gas chromatography-mass spectrometry. The identities of metabolites were established by retention time indices and mass chromatograms. In the steady state of a multiple-dose regimen, the urinary metabolites of theophylline identified and quantified were caffeine (9.6 plus or minus 4.8%), theophylline (50.4 plus or minus 6.7%), 3-methylxanthine (1.3 plus or minus 0.7%), 1,3-dimethyluric acid (27.7% plus or minus 8.8%), and 1-methyluric acid (9.3 plus or minus 5.4%). Those in plasma were caffeine (21.4 plus or minus 6.1%), theophylline (73.6 plus or minus 6.5%), 3-methylxanthine (0.7 plus or minus 0.4%), 1,3-dimethyluric acid (2.6 plus or minus 1.2%), and 1-methyluric acid (0.6 plus or minus 0.3%). Occasionally, theobromine, the metabolic breakdown product of caffeine, was found in urine and plasma in small quantities. The demethylation pathway occurring predominantly in adults was substituted by N-methylation to caffeine in premature infants; the other major metabolic pathway of theophylline in adults, C-8 oxidation to 1,3-dimethyluric acid, was slightly diminished. We concluded that the enzyme systems responsible for the C-8 oxidation of theophylline are relatively active in premature infants and that the development of the enzyme systems responsible for oxidative demethylation of theophylline lags behind. The oxidation and demethylation pathways of theophylline in premature infants are significant.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7214789     DOI: 10.1038/clpt.1981.83

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

Review 1.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

2.  Differential effects of cimetidine on theophylline metabolic pathways.

Authors:  J J Grygiel; J O Miners; R Drew; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 3.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 4.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

5.  Polymorphism of theophylline metabolism in man.

Authors:  C A Miller; L B Slusher; E S Vesell
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

Review 6.  Pharmacokinetics in the infant.

Authors:  R L Milsap; W J Jusko
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.